Ogura Ichiro, Sasaki Yoshihiko, Kameta Ayako, Sue Mikiko, Oda Takaaki
Department of Radiology, The Nippon Dental University Niigata Hospital, Niigata, Japan.
Department of Oral and Maxillofacial Radiology, The Nippon Dental University School of Life Dentistry at Niigata, Niigata, Japan.
Pol J Radiol. 2017 Sep 15;82:551-560. doi: 10.12659/PJR.902513. eCollection 2017.
To assess multimodal imaging features of medication-related osteonecrosis of the jaw (MRONJ) and to analyze the differences between oral and parenteral routes of medication administration. We retrospectively reviewed panoramic radiographs, CT, MRI, and bone scintigraphy of patients with MRONJ.
MATERIAL/METHODS: A retrospective study was conducted in 16 patients with MRONJ who underwent panoramic radiography, CT, MRI, and bone scintigraphy. Statistical analysis for the comparison between routes of medication administration and multimodal imaging features was performed with the Pearson's χ test.
The percentage of cases with sequestrum separation was 25.0% (4/16 cases) on panoramic radiography and 81.3% (13/16 cases) on CT. The percentage of cases with periosteal bone proliferation on CT was 41.7% (5/12 cases) in the oral route of administration 100% (4/4 cases) in the parenteral route of administration (p=0.042). The percentage of cases with spread of soft tissue inflammation to buccal and other spaces on CT and MRI was 33.3% (4/12 cases) in the oral route of administration 100% (4/4 cases) in the parenteral route of administration (p=0.021).
The sequestrum separation on panoramic radiography in patients with MRONJ was unclear in comparison to CT. Furthermore, characteristic CT findings of patients with MRONJ in the parenteral administration group were periosteal bone proliferation and spread of soft tissue inflammation to buccal and other spaces.
评估颌骨药物相关性骨坏死(MRONJ)的多模态影像学特征,并分析口服和肠外给药途径之间的差异。我们回顾性分析了MRONJ患者的全景X线片、CT、MRI和骨闪烁显像。
材料/方法:对16例接受全景X线摄影、CT、MRI和骨闪烁显像的MRONJ患者进行回顾性研究。采用Pearson卡方检验对给药途径与多模态影像学特征之间的差异进行统计学分析。
全景X线片上死骨分离病例的比例为25.0%(4/16例),CT上为81.3%(13/16例)。CT上骨膜骨增生病例的比例在口服给药途径中为41.7%(5/12例),在肠外给药途径中为100%(4/4例)(p=0.042)。CT和MRI上软组织炎症蔓延至颊部和其他间隙病例的比例在口服给药途径中为33.3%(4/12例),在肠外给药途径中为100%(4/4例)(p=0.021)。
与CT相比,MRONJ患者全景X线片上的死骨分离情况不清晰。此外,肠外给药组MRONJ患者的特征性CT表现为骨膜骨增生以及软组织炎症蔓延至颊部和其他间隙。